Caplin Point Laboratories has commenced commercial Production at its state of art injectable Plant near Gummidipoondi, Tamil Nadu on March 27, 2014 to cater regulated markets USA, EU, Brazil, South Africa etc. This will now enable export of these products to Semi regulated and non regulated markets.
The Company has initiated the process of submitting required documents for obtaining approval from regulatory bodies such as UKMHRA, ANVISA, BRAZIL, USFDA, EUGMP which would enable export of Injectables in various dosage forms to the regulated markets besides offering contract manufacturing for export to these markets.
Caplin Point Laboratories is engaged in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: